Heritage Wealth Management (Ohio)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$924K Buy
6,052
+7
+0.1% +$1.07K 0.46% 61
2025
Q4
$833K Hold
6,045
0.23% 106
2025
Q3
$775K Sell
6,045
-100
-2% -$12.2K 0.23% 105
2025
Q2
$744K Sell
6,145
-41
-0.7% -$4.62K 0.24% 102
2025
Q1
$690K Buy
6,186
+50
+0.8% +$5.32K 0.23% 105
2024
Q4
$597K Hold
6,136
0.2% 118
2024
Q3
$706K Hold
6,136
0.23% 112
2024
Q2
$663K Buy
+6,136
New +$616K 0.22% 109

Other funds holding NVS

Heritage Wealth Management (Ohio)'s NVS Position: Q1 2026 in Review

Heritage Wealth Management (Ohio) increased its Novartis (NVS) stake by 0.12% in Q1 2026, buying an estimated $1.07K and bringing the position to 6,052 shares worth $924K. The position accounts for 0.46% of the portfolio, ranked #61.

Heritage Wealth Management (Ohio) first reported a position in NVS in Q2 2024 and has held it in 8 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Heritage Wealth Management (Ohio) held 6,052 shares of Novartis worth $924K as of Q1 2026.
  • Heritage Wealth Management (Ohio) bought 7 Novartis shares in Q1 2026, an estimated $1.07K.
  • Novartis made up 0.46% of Heritage Wealth Management (Ohio)'s portfolio in Q1 2026, its #61 holding.
  • Heritage Wealth Management (Ohio) first reported a position in Novartis in Q2 2024 and has held it in 8 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Heritage Wealth Management (Ohio)'s 13F filing for Q1 2026, filed 20 Apr 2026.